Recent advances in the role of Yes‐associated protein in dermatosis

Abstract

AbstractBackgroundDermatosis is a general term for diseases of the skin and skin appendages including scleroderma, psoriasis, bullous disease, atopic dermatitis, basal cell carcinoma, squamous cell carcinoma, and melanoma. These diseases affect millions of individuals globally and are a serious public health concern. However, the pathogenesis of skin diseases is not fully understood, and treatments are not optimal. Yes‐associated protein (YAP) is a transcriptional coactivator that plays a role in the regulation of gene transcription and signal transduction.AimsTo study the role of Yes‐associated protein in skin diseases.Materials and MethodsThe present review summarizes recent advances in our understanding of the role of YAP in skin diseases, current treatments that target YAP, and potential avenues for novel therapies.ResultsAbnormal YAP expression has been implicated in occurrence and development of dermatosis. YAP regulates the cell homeostasis, proliferation, differentiation, apoptosis, angiopoiesis, and epithelial‐to‐mesenchymal transition, among other processes. As well as, it serves as a potential target in many biological processes for treating dermatosis.ConclusionsThe effects of YAP on the skin are complex and require multidimensional investigational approaches. YAP functions as an oncoprotein that can promote the occurrence and development of cancer, but there is currently limited information on the therapeutic potential of YAP inhibition for cancer treatment. Additional studies are also needed to clarify the role of YAP in the development and maturation of dermal fibroblasts; skin barrier function, homeostasis, aging, and melanin production; and dermatosis.